Innovative drug, Sofosbuvir, to treat hepatitis C is
100% subsidised in Portugal since Tuesday evening and will be given to
all patients who need it.
Eurico Castro Alves was speaking at the end of a meeting with the
administrators of all hospital that treat hepatitis C in Portugal,
Infarmed and the secretary of state of health.
Alves said that an agreement had been signed with the laboratory
that makes Sofosbuvir and the drug is now 100% state subsidised.
Infarmed chairman said that all patients who needed the treatment would
receive the drug and added that there are currently 602 receiving
Labels: access to treatment, Portugal, Sofosbuvir, subsidy